Bayer PE Ratio 2006-2019 | BAYRY

Current and historical p/e ratio for Bayer (BAYRY) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bayer PE ratio as of July 08, 2020 is 9.47.
Bayer PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
0.00 nan
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $66.435B $48.230B
Bayer AG, best known for its flagship product, Bayer Aspirin, produces a broad range of health care, crop protection, polymer, and chemical products that help diagnose and treat diseases, purify water, preserve local landmarks, protect crops, advance automobile safety and durability, and improve people's lives.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $376.352B 16.09
Roche Holding AG (RHHBY) Switzerland $298.663B 0.00
Novartis AG (NVS) Switzerland $200.948B 15.71
Merck (MRK) United States $198.697B 14.39
Pfizer (PFE) United States $189.031B 11.73
Eli Lilly (LLY) United States $159.488B 25.81
Novo Nordisk (NVO) Denmark $153.203B 25.51
AbbVie (ABBV) United States $146.714B 10.77
AstraZeneca (AZN) United Kingdom $140.325B 28.90
Sanofi (SNY) $128.788B 14.91
GlaxoSmithKline (GSK) United Kingdom $101.294B 12.09
H Lundbeck (HLUYY) Denmark $7.727B 13.43
Innoviva (INVA) United States $1.379B 7.96